chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had cramping, pinching pain in his left superior trapezius/supraspinatus thinking brachial plexus involvement; had cramping, pinching pain in his left superior trapezius/supraspinatus thinking brachial plexus involvement; This is a spontaneous report from a contactable other health professional (patient).  A 65-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0149), via an unspecified route of administration in arm left on 22Dec2020 09:45 at single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID tested post vaccination and did not have COVID prior vaccination.  Medical history included known allergies: Sulpha, PCN.  Concomitant medication included famotidine (PEPCID).  The patient had cramping, pinching pain in his left superior trapezius/supraspinatus thinking brachial plexus involvement on 23Dec2020.  The patient did not received treatment. Duration 10 days. Resolved without intervention. The outcome of events was recovered  on 02Jan2021.
Information has been received from a female physician reporting on herself, who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (lot#, dose and route not reported). Physician reported that in approximately 1995 ("approximately 17 years ago") she developed chicken pox following vaccination with VARIVAX (Merck) and on unspecified date she recovered. Additional information is not expected.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 10-MAY-2016, the patient was vaccinated with M-M-R II injection, intramuscularly (exact dose, therapy type, lot # and expiration date were not reported). On 10-MAY-2016, the patient experienced pain at the injection site. The outcome of the event and causality assessment were not provided. Additional information has been requested.
15x12 cm area of redness on his right thigh. Zyrtec and Benadryl for itching.
Mother reported that on 1/12/07 patient was found in dorm room shaking rapidly, unarousable for several minutes, dizzy when she did awaken and complain of headache next day. College infirmary said normal BP and neuro status intact. Patient denies use of any alcohol or drugs.
2 days p/vax pt exp tenderness @ vax site, erythema, induration; no fever;
This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient. A 70 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 70 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.The following information was reported: FALL (non-serious) with onset 23Mar2021, outcome "unknown", described as "He fell yesterday"; LIGAMENT SPRAIN (non-serious), MUSCLE SPASMS (non-serious) all with onset 23Mar2021, outcome "unknown" and all described as "suffered a severe sprain to his right hamstring with muscle spasms"; PAIN (non-serious) with onset 23Mar2021, outcome "unknown", described as "pain". Therapeutic measures were taken as a result of fall, ligament sprain, muscle spasms, pain.No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.Additional Information included The patient had fell while running and suffered a severe sprain to his right hamstring with muscle spasms. He is taking tramadol every 4 hours and is using a lidocaine patch for 12 hours daily and removed at night. The  patient was prescribed to be on Tramadol every 4 hours and he has Lidocaine patch. He wants to know if he can take the medication since he is in pain.
2 days after my moderna vaccine I developed a burning sensation on my tongue like I ate something very hot. As of today, 9/23/2021, I am still dealing with this burning sensation as well as swelling of the tongue.
At around 9:30 am, as per mother, the child developed severe swelling to both lips that continued to worsen. The child was brought back to the clinic and vital signs were assessed: Blood pressure was 110/74, pulse 65. At 10 am, 0.5 ml of epinephrine and 1 ml of Benadryl were administered. At the time of assessment, the child was not showing any of symptoms of difficulty breathing or lethargy. EMS was called for further assessment and the child was transported via ambulance to Medical Center. Child was discharged a couple of hours later from the hospital and has remained stable.
AFIB, chills, fever, elevated heart rate  phone heart app registered my heart rate increate from 75 to 95 bpm at 8:17pm while laying down. at 9:47 heart rate was at 108 and remained above 100 until 4am From 9pm 3/19/20 until falling asleep at 4am.  I experience cold chills and fever. iphone heart app shows BPM slowly reducing from 106 at 4am to 74 at 9:35am 3/20/20 woke up at 9:45 and heart rate was now at 115 laying down in bed At 10:05 am i registered a BPM of 163 and was in AFIB At 10:15 I took my daily Eliquis and Metropolo At 10:45 I took 3 x Flecainide 100mg tablet for AFIB. I remained in AFIB with heart rate between 165 and 104 until 1:19pm 3/20/20 At 1:20 pm I was out of AFIB
chest pain; This is a spontaneous report from a contactable Consumer (patient, self-reported). A 45-Years-old Female patient (age at vaccination: 45 year) received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, in Arm Left, on 06Mar2021 at 12:45 PM, as a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient did not have any known allergies. Concomitant medication included atorvastatin (LIPITOR). The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. The patient reported that on 07Mar2021 at 03:00 PM, she experienced chest pain. The patient did not receive any treatment for the event. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
had the booster vaccine on 11/22/2021 in the morning  and started with palpitation in the evening.
Lack of response - Information has been received from a registered nurse concerning a female in her 30's with an exposure to her mother who has shingles.  Prior to 23 may 2000, the patient was vaccinated with one dose of varicella virus vaccine live (site unknown) number of doses unspecified.  On 23 may 2000 the reporter indicated that recently the patient had a negative titer.  The patient sought unspecified medical attention.
pt in died in SNF, diagnosed positive for COVID on 1/12/22; per death certificate causes of death were:  COVID 19 and age related deterioration
?Moderna COVID-19 Vaccine EUA administered at approx. 11:30 am Saturday morning. I woke up at 4:00 am Sunday morning (Easter) having aches. Throughout the day I have run a temperature of 99.5 to 99.7 degrees.  I experienced some diarrhea at 5:00 pm.
Rt arm red and swollen 2 in x 2 in varicella/MMR that arm. Left arm red and swollen 6 in x 6 in. DTAP in this arm. Mom states child  was playing at park passed out and threw up. Providers don't feel related.
Chronic Headache; Persisting Fatigue; Myalgias; Costochondritis; Hypersomnolence - all sx began within 15 days of vaccine administration and have persistedover last 4+ months. Alternate etiology through extensive testing has yet to be identified. Patient did have Positive CMV titers less than 1 month after onset of symptoms. She also has a markedly positive ANA (1:640) with ongoing Rheumatology evaluation.
Numbness; Tingling feeling down on her lower left leg going up to face to her eyebrow; Left side of her body was stiff; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness), PARAESTHESIA (Tingling feeling down on her lower left leg going up to face to her eyebrow) and MUSCULOSKELETAL STIFFNESS (Left side of her body was stiff) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02UM20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness) and PARAESTHESIA (Tingling feeling down on her lower left leg going up to face to her eyebrow). 28-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Left side of her body was stiff). On 03-Mar-2021, HYPOAESTHESIA (Numbness), PARAESTHESIA (Tingling feeling down on her lower left leg going up to face to her eyebrow) and MUSCULOSKELETAL STIFFNESS (Left side of her body was stiff) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was unknown.
The patient received the Pfizer COVID vaccine and did not have any apparent reaction initially.  Sixteen days after vaccination, the patient developed pain in her neck and shortness of breath. ER evaluation revealed a DVT in her right brachiocephalic vein and acute pulmonary embolism.
pt recv vax 17OCT97 & w/in a few days dx w/aseptic meningitis;hosp is presumed although not documented;
Mild fever, malaise, myalgias lasting more than 16 hours, mostly responding to antipyretic medication (alternately taking acetaminophen and ibuprofen). Also tenderness and soreness with movement at the injection site (like most vaccinations).
Received 2 doses, experienced pain in arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.     Additional Information: GSK Receipt Date: 29-MAR-2022 Reporter's Comment: The patient's daughter reported this case. The patient received dose of Shingrix vaccine between 4 to 5 years ago from reporting date and experienced arm pain that eventually resolved.   The reporter did not consent to follow-up. Additional supportive information: This case had been linked with case US2022056751 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022056751:Same reporter.
pt recvd vax;early eve,large lump at inj site;by early am,rt elbow to shoulder swollen w/ little redness;no pain;by 4pm still reddened,flexall applied;PC MD;28oct arm reddened & firm;in hosp for cellulitis;had t & chills;given ATB;
Hives on arms, legs & abdomen. Oral over-the-counter antihistamine.
Information has been received from a 52 year old female with no pertinent medical history and no drug reactions or allergies who on 06-APR-2011 was vaccinated SC with a dose of ZOSTAVAX (Merck) (lot # and dose not reported). There was no concomitant medication. On 19-May-2011, the patient experienced "chest pain, shortness of breath, tightness in her chest" a couple of weeks after having the ZOSTAVAX (Merck). She went to her cardiologist in the Emergency Room and they diagnosed her with pericarditis. The patient was treated with "Pain medication in IV form". "Blood work, electrocardiography (EKG) and x-ray" were performed (results not reported). At the time of the report, the patient was recovering. Follow up information was received from the patient with drug reactions/allergies to BETADINE and no pertinent medical history who in early April 2011 (previously reported as 06-APR-2011) was vaccinated with a dose of ZOSTAVAX (Merck). In "Late April 2011", the patient stated that she developed pericarditis from ZOSTAVAX (Merck). The patient also stated she was hospitalized twice and felt like she was having a heart attack. Patient was treated with MOTRIN for the swelling. Additional information has been requested.
rapid heart beat; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid heart beat) and VACCINATION SITE PAIN (pain at injection site) in a 71-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced HEART RATE INCREASED (rapid heart beat) and VACCINATION SITE PAIN (pain at injection site). On 18-Feb-2021, HEART RATE INCREASED (rapid heart beat) had resolved. On 19-Feb-2021, VACCINATION SITE PAIN (pain at injection site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Heart rate: inconclusive (Inconclusive) rapid heart beat.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided. for mRNA-1273 (Moderna COVID-19 Vaccine) (intramuscular), the reporter did not provide any causality assessment.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Patient mentioned that event pain at vaccination site lasted for 10 days.
Dizziness, blurred vision, nausea  within 15 minutes and lasting approximately 7-9 hours. Symptoms improved within 2 hours after dose of 10mg cetirizine.
Patient's mom called reporting patient is experiencing minor swelling and tingling in her fingers. This is occurring on her left hand which is the same side she received her vaccine today. At this time, she reports no other symptoms. Mom was advised to monitor the patient for worsening symptoms, and she has a call out to her pediatrician's after-hours service.
pt recvd vax 9JUN93; PE neg then on 17JAN93 fever 103 R; generalized rash began 13JUN gone by 17JUN; examined 19JUN t103; enlarged nodes;
This spontaneous report was received from a registered nurse refers to her 71 year old female patient. On an unknown date the patient was vaccinated with ZOSTAVAX (dosage regimen, lot # and expiry date not provided) for vaccination. On an unknown date the nurse reported that one of her friends developed shingles (reported as a while ago). The outcome of the event was unknown. Additional information is not expected.
8 days post injection I developed itching, redness and swelling at the injection site Potentially unrelated I also developed a fever blister Potentially unrelated I also developed sore, itchy bumps under both armpits. These first appeared 3 days post injection and are still present 8 days post injection
1 dose (1/14/2021) - just having a low grade fever but manageable, then after a week the injection site on my right arm got swollen and itchy. So i took my antihistamine medicine.  2nd dose (1/15/21) - my body feels weak after 18 -20 hours of injection, then starting to have fever(high) and chills., with headache and no sensation of taste. The injection side is swollen (left arm). Then until now still experiencing low grade fever and chills.  I took paracetamol in every 6 hours,  my chills is disappearing with the effect of medicine but the fever is still there.
One hour after the vaccine shot in my left arm shoulder, I see swollen, bulged black darkened nerves/veins in my left hand fingers/knucksles and palm region with moderate sharp pain.   I see numbness on the same left hand side fingers.  I see similar symptoms on my right foot with swollen and enlarged nerves with dark color. The foot area has moderate sharp pain.  32 hours after, I experienced sharp pain on back of my left leg thigh area. Bit sensitive to touch and feel the pain. Not sure these are symptoms of vericose veins or thrombosis kind.
Area of shot was sore for two days.  Used warm compress and took Tylenol to make the pain go away.  Felt very tired.  I had some diarrhea.  Drank plenty of water and pedialyte.  I ran a low grade fever all day Saturday.  99.4F.  My appetite was also affected.
Pt is a 60 yo, with multiple comorbidities including newly diagnosed atrial fibrillation on Eliquis, history of diastolic congestive heart failure, history of coronary artery disease status post PCI to RCA following MRI 2016, hypertension, AML on chemotherapy, metastatic carcinoid tumor of abdomen, dyslipidemia, mood disorder, obstructive sleep apnea on CPAP, tobacco abuse, obesity, GERD, BPH presented to the ED complaints of shortness of breath According to patient he had COVID-19 symptoms for 5 days and was seen by his primary care physician and was found to be in atrial fibrillation with RVR and was sent to emergency room for further evaluation and treatment.  Patient states that he had some cough, nausea, myalgia and loss of smell and taste with some nasal congestion but denies any chest pain.  Patient denies any fever but has some chills.  History of congestive heart failure and atrial fibrillation he has been taking his Eliquis and Bumex daily.  Patient was scheduled for cardiac ablation yesterday but this was canceled secondary to positive COVID-19.  Patient states that he was vaccinated for COVID-19 and had booster.   Chest x-ray showed bilateral infiltrates compatible with COVID-19 pneumonia. His lab showed elevated white count at 17.9 hemoglobin 9.4 previously at 8 platelets 78 sodium 134 potassium 3.2 and was replaced glucose 155 creatinine 1.8 previously at 0.9 AST 146 ALT 81 BNP 682 and started on Bumex troponin was 18.9 lactic acid 2.4 magnesium 1.7 and was replaced LDH 702 CRP 19 procalcitonin 0.21 D-dimer was 12761.   Assessment and plan:  Acute respiratory failure with hypoxia secondary to COVID-19 virus pneumonia and diastolic congestive heart failure exacerbation.  Respiratory protocol, oxygen to keep pulse ox above 90%, Cardiology consult, contact and droplet precaution, steroids, antibiotics, bronchodilators, mucolytics, pulmonary toileting.   Acute kidney injury on admission secondary to dehydration, avoid nephrotoxin medications, hold lisinopril and diuretics   Sepsis most likely secondary to above, antibiotics, cultures pending, monitor vital signs, follow inflammatory markers.   PT OT recommended post acute but patient declined and wanted to go home.
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable consumer (patient). A 23-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), 1st dose via an unspecified route of administration, administered in arm left on 28Jan2021 as a single dose, 2nd dose via an unspecified route of administration, administered in arm left on 17Feb2021 as a single dose; both at age of 23 years old for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient contracted COVID-19 after being fully vaccinated on 01May2021. No treatment was received for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. And the patient had no COVID-19 prior vaccination. The report was reported as non-serious. The patient underwent lab tests and procedures which included PCR test: positive (nasal swab) on 04May2021. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This case was reported by a consumer via call center representative and described the occurrence of injection site tenderness in a 50-year-old female patient who received FLUARIX QUADRIVALENT. Previously administered products included Flu vaccine (Flu vaccination without any reaction). Concurrent medical conditions included hypothyroidism. Concomitant products included Vitamin D3, spironolactone and ARMOUR THYROID. On 11th October 2016, the patient received FLUARIX QUADRIVALENT (intramuscular). On 12th October 2016, 1 days after receiving FLUARIX QUADRIVALENT, the patient experienced injection site tenderness, injection site swelling, injection site erythema, injection site induration and fatigue. On 13th October 2016, the patient experienced nausea, headache, vertigo and general physical health deterioration. On an unknown date, the outcome of the injection site tenderness, injection site swelling, fatigue and headache were recovering/resolving and the outcome of the injection site erythema, injection site induration, nausea and vertigo were recovered/resolved and the outcome of the general physical health deterioration was unknown. The reporter considered the injection site tenderness, injection site swelling, injection site erythema, injection site induration, fatigue, nausea, headache, vertigo and general physical health deterioration to be probably related to FLUARIX QUADRIVALENT. Additional details were provided as follows: The patient had receive the flu vaccine for years without any reaction. The reporter stated that she was administered a dose of FLUARIX QUADRIVALENT after 6 PM on left deltoid. The next day, about 24 hours later, the patient came back from a run, and her daughter noticed that her arm was red and swollen around the injection site. The patient had a hard lump directly at the injection site, and the redness and swelling extended beyond the lump, but did not leave her upper arm. Her arm was also a little sore, and she felt fatigued so she went to bed. On 13th October 2016, the patient woke up and still felt fatigued and her arm had really started hurting, Around noon the patient stated going downhill. The patient experienced extreme vertigo accompanied by nausea. The fatigue had become extreme and she had a headache. The symptoms were so bad that when the patient contacted her health care professional they sent her to the emergency room, where the patient got treatment. The patient started improving after the visit to the emergency room and was sent home that evening. During the night the patient started feeling better, but would get some vertigo and nausea if she moved her head. At the time of reporting the patient was feeling much better. The patient still had some fatigue and a headache, but the vertigo and nausea have resolved. The lump at the injection site had gone away over the course of the day. There was still a little swelling and tenderness at the injection site, but it was much improved compared to day before. It was thought by the patient's health care professional and the emergency room physicians that this was a reaction to the vaccine. It was also thought the nausea was caused by the vertigo.